Relation of High Lipoprotein (a) Concentrations to Platelet Reactivity in Individuals with and Without Coronary Artery Disease-Reference-Cited by-同舟云学术

Relation of High Lipoprotein (a) Concentrations to Platelet Reactivity in Individuals with and Without Coronary Artery Disease

Published:2020-09-05 Issue:11 Volume:37 Page:4568-4584
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Salsoso Rocío^ORCID,Dalcoquio Talia F.,Furtado Remo H. M.,Franci André,Barbosa Carlos J. D. G.,Genestreti Paulo R. R.,Strunz Celia M. C.,Lima Viviane,Baracioli Luciano M.,Giugliano Robert P.,Goodman Shaun G.,Gurbel Paul A.,Maranhão Raul C.,Nicolau Jose C.

Funder

Fundação de Amparo à Pesquisa do Estado de São Paulo

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12325-020-01483-y.pdf

Reference48 articles.

1. Borrelli MJ, Youssef A, Boffa MB, Koschinsky ML. New frontiers in Lp(a)-targeted therapies. Trends Pharmacol Sci. 2019;40:212–25. https://doi.org/10.1016/j.tips.2019.01.004.

2. Erqou S, Kaptoge S, Perry PL, et al. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA. 2009;302:412–23. https://doi.org/10.1001/jama.2009.1063.

3. Clarke R, Peden JF, Hopewell JC, et al. Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med. 2009;361:2518–28. https://doi.org/10.1056/NEJMoa0902604.